慢性病通过炎症酶路径激活促进心房动
Jia Song1, Jose Alberto Navarro-Garcia2,3, Jiao Wu4
1Department of Medicine (Cardiovascular Research).
The Journal of clinical investigation
|August 15, 2023
概括
慢性病 (CKD) 通过激活心房中的NLRP3炎症酶来增加心房动 (AF) 的风险. 在CKD模型中抑制NLRP3或IL-1β可降低AF发生率和心房重塑.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病 (CKD) 增加了心房动 (AF) 的风险,但潜在的机制尚不清楚.
- NLRP3炎症酶及其效应体IL-1β与AF和CKD等与炎症相关的疾病有关.
- 在患有AF的CKD患者中观察到 IL-1β水平升高和NLRP3活性增强.
研究的目的:
- 调查NLRP3/IL-1β信号在CKD背景下AF发展中的作用.
- 为了确定是否针对NLRP3或IL-1β可以减轻CKD诱导的AF.
主要方法:
- 在CKD的小鼠模型中,使用亚总切除协议建立了CKD.
- 基因改造小鼠 (Nlrp3-/-) 或用抗IL-1β抗体治疗,以抑制NLRP3炎症酶激活.
- 在CKD和对照组中评估了心脏结构,电生理学和AF易感性.
主要成果:
- 在野生型小鼠中,CKD诱导了血清和心房IL-1β水平的升高,增加了AF敏感性和延长了AF持续时间.
- 慢性结核病小鼠表现出缩短的心房有效耐火期,心房膨胀和心房纤维化.
- 基因NLRP3抑制或抗IL-1β抗体治疗使心房尺寸正常化,纤维化减少,AF发病率降低.
结论:
- CKD通过在心房中的NLRP3炎症酶激活促进AF的发展,从而导致结构和电力重塑.
- 针对NLRP3/IL-1β通路,特别是用IL-1β中和抗体,显示出预防CKD诱导的AF的治疗潜力.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
36
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
36
01:29Acute Kidney Injury II: Pathophysiology
30
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
30
01:28Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
01:24Chronic Kidney Disease II: Clinical Manifestations
30
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
30
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
35
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
01:23Rheumatic Heart Disease I: Introduction
16
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
16